These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 36124799)

  • 1. CRISPRtracrRNA: robust approach for CRISPR tracrRNA detection.
    Mitrofanov A; Ziemann M; Alkhnbashi OS; Hess WR; Backofen R
    Bioinformatics; 2022 Sep; 38(Suppl_2):ii42-ii48. PubMed ID: 36124799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tracrRNA and Cas9 families of type II CRISPR-Cas immunity systems.
    Chylinski K; Le Rhun A; Charpentier E
    RNA Biol; 2013 May; 10(5):726-37. PubMed ID: 23563642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. crRNA and tracrRNA guide Cas9-mediated DNA interference in Streptococcus thermophilus.
    Karvelis T; Gasiunas G; Miksys A; Barrangou R; Horvath P; Siksnys V
    RNA Biol; 2013 May; 10(5):841-51. PubMed ID: 23535272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction and diversity of tracrRNAs from type II CRISPR-Cas systems.
    Chyou TY; Brown CM
    RNA Biol; 2019 Apr; 16(4):423-434. PubMed ID: 29995560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tracrRNA in CRISPR Biology and Technologies.
    Liao C; Beisel CL
    Annu Rev Genet; 2021 Nov; 55():161-181. PubMed ID: 34416117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative genomics and evolution of trans-activating RNAs in Class 2 CRISPR-Cas systems.
    Faure G; Shmakov SA; Makarova KS; Wolf YI; Crawley AB; Barrangou R; Koonin EV
    RNA Biol; 2019 Apr; 16(4):435-448. PubMed ID: 30103650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient Multiple Genome Modifications Induced by the crRNAs, tracrRNA and Cas9 Protein Complex in Zebrafish.
    Kotani H; Taimatsu K; Ohga R; Ota S; Kawahara A
    PLoS One; 2015; 10(5):e0128319. PubMed ID: 26010089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reprogrammed tracrRNAs enable repurposing of RNAs as crRNAs and sequence-specific RNA biosensors.
    Liu Y; Pinto F; Wan X; Yang Z; Peng S; Li M; Cooper JM; Xie Z; French CE; Wang B
    Nat Commun; 2022 Apr; 13(1):1937. PubMed ID: 35410423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and Evolution of Cas9 tracrRNAs.
    Dooley SK; Baken EK; Moss WN; Howe A; Young JK
    CRISPR J; 2021 Jun; 4(3):438-447. PubMed ID: 34152211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accounting for small variations in the tracrRNA sequence improves sgRNA activity predictions for CRISPR screening.
    DeWeirdt PC; McGee AV; Zheng F; Nwolah I; Hegde M; Doench JG
    Nat Commun; 2022 Sep; 13(1):5255. PubMed ID: 36068235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving Stability and Specificity of CRISPR/Cas9 System by Selective Modification of Guide RNAs with 2'-fluoro and Locked Nucleic Acid Nucleotides.
    Sakovina L; Vokhtantsev I; Vorobyeva M; Vorobyev P; Novopashina D
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilization of the CRISPR/Cas9 system for the efficient production of mutant mice using crRNA/tracrRNA with Cas9 nickase and FokI-dCas9.
    Terao M; Tamano M; Hara S; Kato T; Kinoshita M; Takada S
    Exp Anim; 2016 Jul; 65(3):275-83. PubMed ID: 26972821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery and Functional Characterization of Diverse Class 2 CRISPR-Cas Systems.
    Shmakov S; Abudayyeh OO; Makarova KS; Wolf YI; Gootenberg JS; Semenova E; Minakhin L; Joung J; Konermann S; Severinov K; Zhang F; Koonin EV
    Mol Cell; 2015 Nov; 60(3):385-97. PubMed ID: 26593719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple Origins and Specific Evolution of CRISPR/Cas9 Systems in Minimal Bacteria (
    Ipoutcha T; Tsarmpopoulos I; Talenton V; Gaspin C; Moisan A; Walker CA; Brownlie J; Blanchard A; Thebault P; Sirand-Pugnet P
    Front Microbiol; 2019; 10():2701. PubMed ID: 31824468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spacer prioritization in CRISPR-Cas9 immunity is enabled by the leader RNA.
    Liao C; Sharma S; Svensson SL; Kibe A; Weinberg Z; Alkhnbashi OS; Bischler T; Backofen R; Caliskan N; Sharma CM; Beisel CL
    Nat Microbiol; 2022 Apr; 7(4):530-541. PubMed ID: 35314780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure of the type V-C CRISPR-Cas effector enzyme.
    Kurihara N; Nakagawa R; Hirano H; Okazaki S; Tomita A; Kobayashi K; Kusakizako T; Nishizawa T; Yamashita K; Scott DA; Nishimasu H; Nureki O
    Mol Cell; 2022 May; 82(10):1865-1877.e4. PubMed ID: 35366394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biogenesis pathways of RNA guides in archaeal and bacterial CRISPR-Cas adaptive immunity.
    Charpentier E; Richter H; van der Oost J; White MF
    FEMS Microbiol Rev; 2015 May; 39(3):428-41. PubMed ID: 25994611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterizing leader sequences of CRISPR loci.
    Alkhnbashi OS; Shah SA; Garrett RA; Saunders SJ; Costa F; Backofen R
    Bioinformatics; 2016 Sep; 32(17):i576-i585. PubMed ID: 27587677
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Guzina J; Chen WH; Stankovic T; Djordjevic M; Zdobnov E; Djordjevic M
    Front Genet; 2018; 9():474. PubMed ID: 30386377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPRstrand: predicting repeat orientations to determine the crRNA-encoding strand at CRISPR loci.
    Alkhnbashi OS; Costa F; Shah SA; Garrett RA; Saunders SJ; Backofen R
    Bioinformatics; 2014 Sep; 30(17):i489-96. PubMed ID: 25161238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.